News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The New England Journal of Medicine Reviews CareFusion Corporation's Chloraprep Study In Patient Safety Controversy


1/30/2014 9:26:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The New England Journal of Medicine tells MassDevice.com that its editors are reviewing a 2010 study published by the journal on the effectiveness of CareFusion's ChloraPrep in fighting surgical site infections after questions arise over financial links between the company and the study's lead author. Editors at the New England Journal of Medicine are reviewing the publication of data from a 2010 study on CareFusion's (NYSE:CFN) ChloraPrep antiseptic, prompted by a federal complaint that called the trial "off label" and "invalid," the journal told MassDevice.com today.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES